Reported Earlier, DBV Technologies Submits BLA To FDA For VIASKIN Peanut Patch In Children Aged 4-7 With Peanut Allergy, Requests Priority Review

Benzinga

2026.09.30 07:43 (GMT+0)

Открыть на Benzinga